Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


12.11.2018

1 Acta Neurol Scand
1 BMC Neurol
1 Curr Opin Immunol
6 Diabetes Res Clin Pract
2 Intern Med
4 J Autoimmun
1 J Clin Endocrinol Metab
2 J Neuroimmunol
1 J Neurol
1 Kidney Int
1 Lancet Neurol
3 Mult Scler
1 Neurology
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. STEENHOF M, Nielsen NM, Stenager E, Kyvik K, et al
    Distribution of disease courses in familial versus sporadic multiple sclerosis.
    Acta Neurol Scand. 2018 Nov 9. doi: 10.1111/ane.13044.
    PubMed     Text format     Abstract available


    BMC Neurol

  2. DEFTEREOS SN, Koutlas E, Koutsouraki E, Kyritsis A, et al
    Seasonal adherence to, and effectiveness of, subcutaneous interferon beta-1a administered by RebiSmart(R) in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study.
    BMC Neurol. 2018;18:186.
    PubMed     Text format     Abstract available


    Curr Opin Immunol

  3. HALE M, Rawlings DJ, Jackson SW
    The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.
    Curr Opin Immunol. 2018;55:81-88.
    PubMed     Text format     Abstract available


    Diabetes Res Clin Pract

  4. JENSEN O, Bernklev T, Gibbs C, Moe RB, et al
    Fatigue in type 1 diabetes, prevalence, predictors and comparison with the background population.
    Diabetes Res Clin Pract. 2018;143:71-78.
    PubMed     Text format     Abstract available

  5. LIN YH, Chen KJ, Peng YS, Chen PC, et al
    Type 1 diabetes impairs female fertility even before it is diagnosed.
    Diabetes Res Clin Pract. 2018;143:151-158.
    PubMed     Text format     Abstract available

  6. GUTIERREZ-MANZANEDO JV, Carral-San Laureano F, Moreno-Vides P, de Castro-Maqueda G, et al
    Teachers' knowledge about type 1 diabetes in south of Spain public schools.
    Diabetes Res Clin Pract. 2018;143:140-145.
    PubMed     Text format     Abstract available

  7. CREANZA A, Lupoli R, Lembo E, Tecce N, et al
    Glycemic control and microvascular complications in adults with type 1 diabetes and long-lasting treated celiac disease: A case-control study.
    Diabetes Res Clin Pract. 2018;143:282-287.
    PubMed     Text format     Abstract available

  8. HUMAYUN MA, Jenkins E, Knott J, Ryder J, et al
    Intensive structured education for type 1 diabetes management using BERTIE: Long-term follow-up to assess impact on glycaemic control and quality of life indices.
    Diabetes Res Clin Pract. 2018;143:275-281.
    PubMed     Text format     Abstract available

  9. FANG C, Li S, Xu R, Guo H, et al
    Soluble B7-H3 (sB7-H3) is over-expressed in the serum of type 1 diabetes patients.
    Diabetes Res Clin Pract. 2018;143:332-336.
    PubMed     Text format     Abstract available


    Intern Med

  10. YABE H
    Paraneoplastic Large-vessel Vasculitis Associated with Myelodysplastic Syndrome.
    Intern Med. 2018;57:2769-2771.
    PubMed     Text format    

  11. ENDO Y, Koga T, Ishida M, Fujita Y, et al
    Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis.
    Intern Med. 2018;57:2247-2250.
    PubMed     Text format     Abstract available


    J Autoimmun

  12. KARA S, Pirela-Morillo GA, Gilliam CT, Wilson GD, et al
    Identification of novel susceptibility genes associated with seven autoimmune disorders using whole genome molecular interaction networks.
    J Autoimmun. 2018 Oct 31. pii: S0896-8411(18)30508.
    PubMed     Text format     Abstract available

  13. CURRAN CS, Gupta S, Sanz I, Sharon E, et al
    PD-1 immunobiology in systemic lupus erythematosus.
    J Autoimmun. 2018 Nov 2. pii: S0896-8411(18)30408.
    PubMed     Text format     Abstract available

  14. KERKAR N, Vergani D
    De novo autoimmune hepatitis -is this different in adults compared to children?
    J Autoimmun. 2018 Nov 2. pii: S0896-8411(18)30600.
    PubMed     Text format     Abstract available

  15. TAUBERT R, Hupa-Breier KL, Jaeckel E, Manns MP, et al
    Novel therapeutic targets in autoimmune hepatitis.
    J Autoimmun. 2018 Nov 3. pii: S0896-8411(18)30601.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  16. DUNN A, Lam A, Hidalgo L, Shapiro AJ, et al
    Autoimmune Thyroid Disease in Islet Transplant Recipients Discontinuing Immunosuppression Late After Lymphodepletion.
    J Clin Endocrinol Metab. 2018 Nov 5. pii: 5155463. doi: 10.1210/jc.2018-01652.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  17. CAVAZZANA I, Alberici A, Bonomi E, Ottaviani R, et al
    Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?
    J Neuroimmunol. 2018;325:61-63.
    PubMed     Text format     Abstract available

  18. SUGIMOTO K, Hiwasa T, Shibuya K, Hirano S, et al
    Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis.
    J Neuroimmunol. 2018;325:54-60.
    PubMed     Text format     Abstract available


    J Neurol

  19. CAO D, Guo X, Yuan T, Hao J, et al
    Diagnosing chronic inflammatory demyelinating polyradiculoneuropathy with triple stimulation technique.
    J Neurol. 2018;265:1916-1921.
    PubMed     Text format     Abstract available


    Kidney Int

  20. MULLER MB, Hoppe JM, Bideak A, Lux M, et al
    Exclusive expression of transmembrane TNF aggravates acute glomerulonephritis despite reduced leukocyte infiltration and inflammation.
    Kidney Int. 2018 Oct 30. pii: S0085-2538(18)30594.
    PubMed     Text format     Abstract available


    Lancet Neurol

  21. DALAKAS MC
    Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy.
    Lancet Neurol. 2018;17:20-21.
    PubMed     Text format    


    Mult Scler

  22. LUIJTEN MA, Eekhout I, D'Hooghe M, Uitdehaag BM, et al
    Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item version.
    Mult Scler. 2018 Nov 9:1352458518808197. doi: 10.1177/1352458518808197.
    PubMed     Text format     Abstract available

  23. LAMERS I, Feys P
    Patient reported outcome measures of upper limb function in multiple sclerosis: A critical overview.
    Mult Scler. 2018 Nov 9:1352458518809294. doi: 10.1177/1352458518809294.
    PubMed     Text format    

  24. HYUN JW, Kim Y, Kim G, Kim SH, et al
    Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis.
    Mult Scler. 2018 Nov 7:1352458518810261. doi: 10.1177/1352458518810261.
    PubMed     Text format     Abstract available


    Neurology

  25. RUCK T, Pfeuffer S, Schulte-Mecklenbeck A, Gross CC, et al
    Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells.
    Neurology. 2018 Nov 7. pii: WNL.0000000000006648.
    PubMed     Text format     Abstract available


    Thyroid

  26. WANG W, Mao J, Zhao J, Lu J, et al
    Decreased Thyroid Peroxidase Antibody Titer in Response to Selenium Supplementation in Autoimmune Thyroiditis and the Influence of a SEPP Gene Polymorphism: A Prospective, Multicenter study in China.
    Thyroid. 2018 Nov 6. doi: 10.1089/thy.2017.0230.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: